Supported by Nesta, Randomise Me has been developed by Ben Goldacre, and is set to revolutionise the ways in which randomised control trials (RCTs) are set up and run.
Randomise Me has been developed in the belief that trials should and could be used much more than they are currently are.
The site will strip out the complexities commonly associated with the method, helping anyone set up a trial and answer the questions they care about, such as "are my heart palpitations caused by drinking coffee?" or "Will brain booster puzzles really help improve exam performance for the children I teach?"
Randomise Me allows you to set up trials to test something on yourself, or to set up a group trial where others can join. There is also the functionality to allow you to run a trial off-line. in each case the site helps structure the trial and analyse the data.
But what are trials and why are they useful? Watch this animation and find out!
At this event Ben Goldacre outlined why Randomise Me has been created, how it works, and why randomised control trials (RCT) are a vital component in helping us to understand what is working.
Ben Goldacre is a widely acclaimed broadcaster, writer, academic and physician. Ben is well known for his Guardian column 'Bad Science' and as the author of 'Bad Pharma' and 'Bad Science'.
Ben Goldacre is a trained physician and is currently a research fellow in epidemiology at the London School of Hygiene and Tropical Medicine. Randomise Me was built by Better Data, a non-profit health IT company run by Ben Goldacre and Carl Reynolds.